ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 73 filers reported holding ENTELLUS MED INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,068,000 | -66.7% | 124,866 | -72.3% | 0.14% | -58.7% |
| Q1 2017 | $6,215,000 | +30.6% | 450,371 | +79.6% | 0.34% | +48.3% |
| Q4 2016 | $4,757,000 | -6.2% | 250,756 | +9.7% | 0.23% | -0.9% |
| Q3 2016 | $5,071,000 | +23.2% | 228,647 | +1.5% | 0.23% | +2.7% |
| Q2 2016 | $4,116,000 | +0.4% | 225,280 | 0.0% | 0.23% | +0.4% |
| Q1 2016 | $4,098,000 | -18.8% | 225,280 | -24.7% | 0.22% | -8.2% |
| Q4 2015 | $5,046,000 | +3.7% | 299,268 | +10.8% | 0.24% | +4.3% |
| Q3 2015 | $4,865,000 | -29.0% | 270,000 | +1.9% | 0.24% | -12.3% |
| Q2 2015 | $6,856,000 | +27.8% | 265,000 | +8.2% | 0.27% | +17.5% |
| Q1 2015 | $5,366,000 | – | 245,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $48,960,000 | 52.70% |
| Discovery Group I, LLC | 2,169,729 | $35,931,000 | 10.38% |
| Essex Woodlands Management, Inc. | 3,231,656 | $53,516,000 | 9.68% |
| Archon Capital Management LLC | 478,820 | $7,929,000 | 6.46% |
| First Light Asset Management, LLC | 512,416 | $8,486,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $5,655,000 | 2.15% |
| Ghost Tree Capital, LLC | 375,000 | $6,210,000 | 1.29% |
| PERKINS CAPITAL MANAGEMENT INC | 68,316 | $1,131,000 | 1.25% |
| Cypress Capital Management LLC (WY) | 63,540 | $1,052,222,000 | 1.21% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 35,000 | $580,000 | 0.66% |